Hi, How Can We Help?

Is Newborn Jaundice Normal and Harmless? 

Posted:    Author:

Harry Whitmore, Medical Student

   Reviewed by:

Dr. Stefan Petrov, MBBS

Newborn jaundice refers to the yellowing of an infant’s skin and eyes, which is a frequent occurrence in the days following birth. This happens because a baby’s body is adjusting to life outside the womb and their liver is not yet fully efficient at removing a substance called bilirubin. While this can be a source of concern for many parents, the majority of cases are part of a normal developmental phase. However, every baby in the United Kingdom is carefully monitored by healthcare professionals to ensure that bilirubin levels remain within a safe range. Understanding the difference between a natural transition and a condition that requires medical attention is a key part of postnatal care. 

What We’ll Discuss in This Article 

  • The definition of physiological jaundice and why it is so common. 
  • How the infant liver processes bilirubin in the first days of life. 
  • The distinction between normal yellowing and pathological conditions. 
  • Standard UK screening procedures and monitoring for newborns. 
  • The role of feeding and hydration in managing bilirubin levels. 
  • Common treatments used in UK hospitals for high bilirubin levels. 

Defining Normal Physiological Jaundice in Infants 

Most cases of newborn jaundice are normal and harmless, occurring as a result of the baby’s liver being temporarily immature and unable to process bilirubin at a fast rate. The NHS explains that newborn jaundice is a common and usually harmless condition in newborn babies that causes yellowing of the skin and the whites of the eyes. This type of yellowing is known as physiological jaundice. It typically appears around the second or third day of life, peaks between the fourth and fifth day, and usually resolves on its own by the time the baby is two weeks old. In babies born prematurely, it may take a little longer to appear and longer to clear. 

Physiological jaundice is not a disease but a sign of the infant’s transition to independent metabolic function. Before birth, the mother’s liver processes bilirubin for the baby. After birth, the baby’s liver must take over this role. Because this transition is not instantaneous, a temporary rise in bilirubin is expected. For most healthy infants, this rise is modest and does not cause any physical discomfort or long-term health issues. 

The Biological Mechanism of Bilirubin Production 

Jaundice develops when there is an accumulation of bilirubin, which is a natural yellow byproduct of the breakdown of red blood cells. Newborns have a higher concentration of red blood cells than adults, and these cells have a shorter lifespan, meaning they are broken down more frequently. 

When red blood cells reach the end of their life cycle, they release haemoglobin, which is eventually converted into unconjugated bilirubin. This form of bilirubin is fat soluble and cannot be easily excreted by the body. It must travel to the liver, where it is converted into a water soluble form called conjugated bilirubin. Because a newborn’s liver is still developing its enzymatic pathways, it cannot always conjugate bilirubin as quickly as the body produces it. The resulting surplus of unconjugated bilirubin circulates in the blood and settles in the skin and the whites of the eyes, creating the characteristic yellow tint. 

Differentiating Between Physiological and Pathological Jaundice 

While most jaundice is harmless, it is classified as pathological if it appears within the first 24 hours of life or if the bilirubin levels reach a point that could be harmful to the infant’s developing nervous system. Jaundice appearing very early is often linked to factors other than liver immaturity, such as blood group incompatibilities between the mother and baby (for example, Rhesus or ABO incompatibility) or underlying infections. 

Feature Physiological Jaundice Pathological Jaundice 
Onset Usually 2 to 3 days after birth Within the first 24 hours of birth 
Duration Resolves within 10 to 14 days May persist beyond 2 to 3 weeks 
Bilirubin Levels Stay within safe, age-appropriate limits May rise rapidly or exceed safe limits 
Treatment Rarely required; usually resolves with feeding Often requires phototherapy or further tests 

Healthcare professionals use these timelines to determine which babies require more intensive monitoring or diagnostic tests. If jaundice is still present after two weeks (or three weeks for premature babies), it is referred to as prolonged jaundice. In the United Kingdom, these infants are usually given a follow-up check to ensure that the jaundice is not caused by rare liver or biliary conditions. 

UK Clinical Monitoring and Screening Protocols 

Healthcare professionals in the United Kingdom use standardised screening tools to monitor every infant for jaundice during the first week of life to ensure safety. NICE clinical guidelines for jaundice in newborn babies provide a framework for midwives and doctors to assess bilirubin levels using visual checks and diagnostic tests. During routine postnatal visits, midwives will examine the baby’s skin in natural light. A common technique involves gently pressing the skin to see if the yellow colour is visible in the underlying tissue. 

Because visual assessment alone can be unreliable, especially in babies with darker skin tones, UK clinicians often use a device called a transcutaneous bilirubinometer. This handheld tool uses light to estimate the level of bilirubin in the skin without needing a needle. If this reading is high, or if the baby is in a higher risk category, a blood test called a Serum Bilirubin (SBR) test is performed to get an exact measurement. These measurements are plotted on a treatment graph that accounts for the baby’s age in hours and their gestational age at birth, ensuring that intervention only occurs when clinically necessary. 

The Importance of Feeding and Hydration 

Frequent feeding is the most effective natural way to help a baby clear bilirubin from their system because it encourages regular bowel movements and provides the energy the liver needs to function. Bilirubin is primarily excreted from the body through the stools. When a baby feeds well, their digestive system remains active, allowing conjugated bilirubin to be passed out of the body as waste. 

If a baby is not feeding adequately, the bilirubin in the gut can be reabsorbed back into the bloodstream, which causes the levels to stay high or increase. Breastfed babies may sometimes have jaundice that lasts slightly longer, which is sometimes referred to as breast milk jaundice. This is a common and harmless occurrence that is thought to be caused by substances in breast milk that temporarily slow down the liver’s processing of bilirubin. In the United Kingdom, mothers are supported by midwives and lactation specialists to ensure effective feeding, as maintaining hydration and nutrition is the first line of management for physiological jaundice. 

Clinical Treatments for High Bilirubin Levels 

When bilirubin levels exceed the specific safety thresholds established by UK clinical guidelines, phototherapy is used to safely break down the pigment so it can be excreted. Phototherapy involves placing the baby under a special type of blue light. This light changes the shape and structure of bilirubin molecules in the skin through a process called photo-oxidation, making them water soluble so they can be filtered by the kidneys and excreted in the urine and stools. 

During phototherapy, the baby is placed in a cot or incubator with as much skin exposed to the light as possible. Their eyes are protected with special shields to prevent irritation from the light. This treatment is highly effective and usually only lasts for a few days until the bilirubin levels have dropped to a safe range. In very rare cases where bilirubin levels are exceptionally high and do not respond to light therapy, more intensive treatments like an exchange transfusion may be considered in a neonatal intensive care unit, although this is uncommon in the UK due to effective early screening. 

Conclusion 

Newborn jaundice is a normal and harmless part of early development for most infants as their livers adjust to life after birth. While the yellowing of the skin and eyes is common, it is essential that every baby is monitored by a healthcare professional during the first days of life. Through standardised UK screening and the support of frequent feeding, the vast majority of cases resolve without the need for medical intervention. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Why is my baby yellow? 

The yellow colour comes from bilirubin, a pigment that builds up because a newborn’s liver is not yet fast enough at removing it.

Is it my fault that my baby has jaundice? 

No, jaundice is a natural biological process related to the baby’s development and is not caused by anything the parents did during pregnancy.

Will my baby need to stay in hospital? 

Most babies with mild jaundice go home as normal, but those with higher levels may stay for a few days of phototherapy.

Can I treat jaundice by putting my baby in the sun? 

No, the NHS does not recommend using sunlight to treat jaundice as it can lead to sunburn and does not provide the controlled light needed for safety.

How long does it take for the yellowing to go away? 

In most healthy babies, the yellowing starts to fade after a week and is completely gone by the time the baby is two weeks old.

Does jaundice mean my baby is ill? 

In most cases, no; it is simply a sign that the baby’s liver is still maturing, though doctors monitor it to be safe. 

What should I look for if the jaundice gets worse? 

You should contact your midwife if your baby becomes very sleepy, is difficult to wake for feeds, or if the yellowing spreads to their arms and legs.

Authority Snapshot (E-E-A-T) 

This article provides medically factual health education regarding newborn jaundice, strictly aligned with NHS and NICE clinical guidelines. The content is developed by a professional medical writing team and reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine, surgery, and emergency care. All information follows current UK public health protocols to ensure accuracy and patient safety. 

Written By Harry Whitmore, Medical Student
Dr. Stefan Petrov, MBBS
Reviewed By Dr. Stefan Petrov, MBBS

Dr. Stefan Petrov is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.